Linda Yaccarino Appointed CEO of eMed Population Health

Strategic Insights -

Linda Yaccarino, the former CEO of X, has been appointed CEO of eMed Population Health, a telehealth firm focused on GLP-1 weight-loss drugs. Despite not having a background in healthcare, Yaccarino brings over a decade of experience in digital revenue and brand partnerships from her time at NBCUniversal and X. She will lead eMed in transforming the category of chronic care management.

Key Takeaways:

  • Linda Yaccarino, former CEO of X, has been appointed CEO of eMed Population Health, a telehealth firm focused on GLP-1 weight-loss drugs.
  • Yaccarino does not have a background in healthcare, but brings over a decade of experience in digital revenue and brand partnerships from her time at NBCUniversal and X.
  • eMed partners with employers and government payers to manage the usage of GLP-1 drugs, a class of obesity and diabetes treatments, which have faced cost-related challenges.
  • The company has moved away from at-home testing and diagnostics for common infections to focus on chronic care management.
  • Yaccarino's appointment is seen as beneficial due to her experience in digital marketing and advertising, which is becoming more important as the industry becomes more direct-to-consumer.
  • Yaccarino's vision is to transform the category at a critical moment, although the company has not specified what this means in concrete terms.

Statistics:

  • Over a decade of experience in digital revenue and brand partnerships at NBCUniversal and X.
  • eMed has focused on managing the usage of GLP-1 drugs, a class of obesity and diabetes treatments.
  • GLP-1 medications have faced cost-related challenges around insurance coverage, despite growing consumer demand.
  • eMed has moved away from at-home testing and diagnostics for common infections to focus on chronic care management.

Sources:

  • Reuters: Linda Yaccarino exits X to join healthcare startup eMed Population Health (2025)
  • Contify.com: Copyright 2025 Best Media Info, distributed by Contify.com (no date specified)